News Drug Development

Novel Targets for TAFI Inhibition Discovered By Researchers From Katholieke Universiteit Leuven In Belgium

November 12, 2008 |

1 min read

MedWire News: Researchers from Belgium have revealed novel mechanisms and molecular targets for the inhibition of activated thrombin activatable fibrinolysis inhibitor (TAFIa).

Preclinical Europe

MORE ON THIS TOPIC

Lungs health and pulmonology as a respiratory medicine conept for pulmonary science and lung cancer or respiration disease and bronchi breathing or asthma symbol in a 3D illustration style.

Clinical research

Sanofi’s $1.4B Kymab Bet Falters as Asthma Drug Stumbles in Phase II

April 16, 2025

·

2 min read

·

Tristan Manalac

European Union flags in front of the blurred European Parliament in Brussels, Belgium

Europe

With Tariffs Looming, EU and US Pharmas Make Demands of European Commission

April 16, 2025

·

2 min read

·

Tristan Manalac

Feb 2, 2020 South San Francisco / CA / USA - Merck & Co. headquarters in Silicon Valley; Merck & Co. Inc. is an American multinational pharmaceutical company

Collaboration

Merck Eyes Oral Peptide Delivery With Cyprumed Deal Worth up to $493M

April 15, 2025

·

2 min read

·

Tristan Manalac

Modern process Heart inner organs disease treatment design concept with Tiny People Character Vector Illustration

Cardiovascular disease

BMS’ Camzyos Fails To Show New Cardiomyopathy Benefit in Phase III

April 15, 2025

·

2 min read

·

Tristan Manalac